...Consideration for 2021: A Biopharma Perspective.” The report, based on in-depth interviews with Market Access leaders from pre-commercial and commercial biopharma companies, finds that the top two challenges for market...
...they create or evolve their center of excellence capabilities With a roster of large, emerging, and precommercial life sciences companies, TGaS Advisors, a division of Trinity, provides robust comparative intelligence...
...now! The webinar will explore the questions: What drives and motivates companies to increase gender diversity in VP/SVP commercial roles? How do companies demonstrate commitment and belief in gender-equity? What...
...the most capable biopharma advisors in the industry.” Editor’s Note: To arrange an interview, contact Katie Ware at katie.ware@bain.com or +1 646 562 8102. About Bain & Company Bain & Company is a global consultancy...
...solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com. Media Contact: Elizabeth Marshall Trinity Life Sciences emarshall@trinitylifesciences.com...
...by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com. For more information: Elizabeth Marshall Trinity Life Sciences 781-577-6376 emarshall@trinitylifesciences.com...
...biopharmaceutical companies. The new offering includes expertise on market access, pricing and contracting along with the best-in-class organizational approaches needed to successfully commercialize biopharmaceutical products. “As public pressure for pricing...
...and emerging life science companies here, as TGaS’ Pricing and Contracting experts discuss common Government Pricing challenges that companies are facing. Topics include: What are the “watch outs” that companies...
...pharmaceutical companies and a growing number of biotech companies. Under terms of the agreement, Trinity will add TGaS’s unique benchmarking products to its real-world evidence and primary market research capabilities...
...misguided focus of manufacturers entering this space Revolution in reimbursement model is needed if CGT market expansion is significant Please see the full white paper here: https://trinitylifesciences.com/thought-leadership/exploring-the-truth-of-reimbursement-challenges-for-cell-and-gene-therapies/ About TRINITY TRINITY is a...
